lobbying_activities: 2861782
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2861782 | 73f1833c-1eac-47c2-808d-ec67391ee782 | 4T | ANDREW VOGT STRATEGIES LLC | 401106004 | ALLIANCE FOR CELL THERAPY NOW | 2022 | fourth_quarter | BUD | Increased funding for research on regenerative medicine and cell therapies at the National Institutes of Health and Department of Health and Human Services; Implementation of the 21st Century Cures Act | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 1 | 2022-10-10T09:58:56-04:00 |